- Home
- CSR vs OPK Comparison
CSR vs OPK Comparison
Compare CSR & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CSR | OPK |
|---|---|---|
| Founded | 1970 | 2006 |
| Country | United States | United States |
| Employees | 349 | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 921.2M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | CSR | OPK |
|---|---|---|
| Price | $62.52 | $1.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $70.50 | $2.03 |
| AVG Volume (30 Days) | 94.4K | ★ 1.9M |
| Earning Date | 01-01-0001 | 05-29-2026 |
| Dividend Yield | ★ 4.99% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $606,879,000.00 |
| Revenue This Year | $2.45 | N/A |
| Revenue Next Year | $1.84 | $4.76 |
| P/E Ratio | $62.27 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $52.76 | $1.11 |
| 52 Week High | $69.15 | $1.87 |
Technical Indicators
Market Signals| Indicator | CSR | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 39.90 |
| Support Level | $60.01 | $1.12 |
| Resistance Level | $68.36 | $1.27 |
| Average True Range (ATR) | 1.42 | 0.05 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 58.17 | 23.08 |
Price Performance
Historical ComparisonAbout CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.